文献速递银屑病与炎症性皮肤病

转谷氨酰胺酶3通过磷酸化STAT3-TET3信号抑制NF-κB活化减轻银屑病皮肤炎症

Transglutaminase 3 Attenuates Skin Inflammation in Psoriasis by Inhibiting NF-κB Activation through Phosphorylated STAT3-TET3 Signaling.
PubMed 文献 · J Invest Dermatol · 2022-05-08

本研究探讨转谷氨酰胺酶3(TGM3)在银屑病发病中的作用及机制,发现银屑病患者皮损及咪喹莫特诱导的小鼠银屑病皮炎模型中TGM3表达增加。TGM3过表达可减少银屑病相关细胞因子刺激的原代角质形成细胞中促炎因子的产生,其机制涉及抑制STAT3磷酸化及TET3向p65基因启动子的募集,从而降低启动子去甲基化并抑制促炎细胞因子/趋化因子产生。局部应用Tgm3特异性小干扰RNA或泛转谷氨酰胺酶抑制剂半胱胺可加重小鼠银屑病皮炎炎症,提示TGM3-TET3相互作用介导的表观遗传通路是银屑病治疗的潜在靶点。

要点

  • 银屑病患者皮损及咪喹莫特诱导的小鼠银屑病皮炎模型中TGM3表达增加。
  • TGM3过表达减少银屑病相关细胞因子刺激的原代角质形成细胞中促炎因子的产生。
  • 局部应用Tgm3特异性小干扰RNA或泛转谷氨酰胺酶抑制剂半胱胺可加重小鼠银屑病皮炎炎症。

核心结论

  • 本研究揭示了TGM3与TET3相互作用介导的表观遗传通路在角质形成细胞中调控银屑病皮肤炎症,为银屑病治疗提供了潜在靶点。

研究设计与样本

  • 研究检测了银屑病患者皮损及咪喹莫特诱导的小鼠银屑病皮炎模型中TGM3的表达,并在培养的原代角质形成细胞及小鼠模型中进行了机制和功能实验。

主要发现

  • 银屑病患者皮损及咪喹莫特诱导的小鼠银屑病皮炎模型中TGM3表达增加。
  • TGM3过表达 decreased 银屑病相关细胞因子刺激的原代角质形成细胞中促炎因子的产生。
  • TGM3抑制STAT3磷酸化及TET3向p65基因启动子的募集,导致启动子去甲基化减少,进而抑制促炎细胞因子/趋化因子产生。
  • TGM3诱导的磷酸化p65抑制也可能降低TET3表达。
  • 局部应用Tgm3特异性小干扰RNA或泛转谷氨酰胺酶抑制剂半胱胺可加重咪喹莫特诱导的小鼠银屑病皮炎炎症。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transglutaminase 3 (TGM3) protects against skin inflammation in psoriasis, but the precise role and mechanism of action of TGM3 in the pathogenesis of psoriasis remain unclear. In this study, we show that TGM3 expression was increased in the skin lesions of patients with psoriasis and a mouse model of imiquimod-induced psoriatic dermatitis. TGM3 overexpression decreased the production of proinflammatory factors in cultured primary keratinocytes stimulated with psoriasis-related cytokines. TGM3 inhibited the phosphorylation of signal transducer and activator of transcription 3 and the recruitment of ten-eleven translocation 3 to the p65 gene promoter, resulting in decreased promoter demethylation and subsequent suppression of proinflammatory cytokine/chemokine production. TGM3-induced inhibition of phosphorylated p65 might also decrease ten-eleven translocation 3 expression. Moreover, topical application of Tgm3-specific small interfering RNA or the pan-transglutaminase inhibitor cysteamine exacerbated skin inflammation in mice with imiquimod-induced psoriatic dermatitis. Our study revealed an epigenetic pathway mediated by the interaction between TGM3 and ten-eleven translocation 3 in keratinocytes for regulation of skin inflammation in psoriasis, providing a potential target for psoriasis treatment.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Ling S, Xu B, Luo Y, et al. Transglutaminase 3 Attenuates Skin Inflammation in Psoriasis by Inhibiting NF-κB Activation through Phosphorylated STAT3-TET3 Signaling. J Invest Dermatol. 2022. PMID: 35545140. doi:10.1016/j.jid.2022.03.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。